Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2019

Open Access 01-12-2019 | Infertility | Research

Assisted conception as a potential prognostic factor predicting insulin therapy in pregnancies complicated by gestational diabetes mellitus

Authors: Azam Kouhkan, Hamid Reza Baradaran, Roya Hosseini, Arezoo Arabipoor, Ashraf Moini, Reihaneh Pirjani, Alireza Khajavi, Mohammad E. Khamseh

Published in: Reproductive Biology and Endocrinology | Issue 1/2019

Login to get access

Abstract

Background

Advanced maternal age, family history of diabetes, pre-gestational obesity, increased level of HbA1c, history of gestational diabetes mellitus (GDM), and poor pregnancy consequences are considered risk factors for antenatal insulin requirement in women with GDM. However, the role of assisted reproductive technology (ART) in increasing the risk of insulin therapy in pregnancies complicated with GDM remained elusive. The current study aimed to determine the role of ART in predicting insulin therapy in GDM women and investigate the clinical and biochemical factors predicting the need for insulin therapy in pregnancies complicated with GDM.

Methods

In this prospective cohort study, 236 Iranian women with GDM were diagnosed by one-step oral glucose tolerance test (OGTT) between October 2014 and June 2017. They were mainly assigned to two groups; the first group (n = 100) was designated as ART which was further subdivided into two subgroups as follows: 60 participants who received medical nutrition therapy (MNT) and 40 participants who received MNT plus insulin therapy (MNT-IT). The second group (n = 136) was labeled as the spontaneous conception (SC), consisting of 102 participants receiving MNT and 34 participants receiving MNT in combination with IT (MNT-IT). The demographic, clinical, and biochemical data were compared between groups. Multivariate logistic regression was performed to estimate prognostic factors for insulin therapy.

Results

A higher rate of insulin therapy was observed in the ART group as compared with the SC group (40% vs. 25%; P < 0.001). Multivariate logistic regression demonstrated that maternal age ≥ 35 years [OR: 2.91, 95% CI: (1.28–6.62)], high serum FBS [1.10: (1.04–1.16)], HbA1c [1.91 (1.09–3.34)], and ART treatment [2.94: (1.24–6.96)] were independent risk factors for insulin therapy in GDM women.

Conclusions

Apart from risk factors mentioned earlier, ART may be a possible prognostic factor for insulin therapy in pregnancies complicated with GDM.
Literature
1.
go back to reference Tobias DK, Chavarro JE, Williams MA, Buck Louis GM, Hu FB, Rich-Edwards J, et al. History of infertility and risk of gestational diabetes mellitus: a prospective analysis of 40,773 pregnancies. Am J Epidemiol. 2013;178(8):1219–25.CrossRef Tobias DK, Chavarro JE, Williams MA, Buck Louis GM, Hu FB, Rich-Edwards J, et al. History of infertility and risk of gestational diabetes mellitus: a prospective analysis of 40,773 pregnancies. Am J Epidemiol. 2013;178(8):1219–25.CrossRef
2.
go back to reference Pinborg A, Wennerholm U-B, Romundstad L, Loft A, Aittomaki K, Söderström-Anttila V, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2012;19(2):87–104.CrossRef Pinborg A, Wennerholm U-B, Romundstad L, Loft A, Aittomaki K, Söderström-Anttila V, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2012;19(2):87–104.CrossRef
3.
go back to reference Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780-86.CrossRef Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780-86.CrossRef
4.
go back to reference Holst S, Kjær SK, Jørgensen ME, Damm P, Jensen A. Fertility problems and risk of gestational diabetes mellitus: a nationwide cohort study. Fertil Steril. 2016;106(2):427–34 e1.CrossRef Holst S, Kjær SK, Jørgensen ME, Damm P, Jensen A. Fertility problems and risk of gestational diabetes mellitus: a nationwide cohort study. Fertil Steril. 2016;106(2):427–34 e1.CrossRef
5.
go back to reference Wang Y, Nikravan R, Smith H, Sullivan E. Higher prevalence of gestational diabetes mellitus following assisted reproduction technology treatment. Hum Reprod. 2013;28(9):2554–61.CrossRef Wang Y, Nikravan R, Smith H, Sullivan E. Higher prevalence of gestational diabetes mellitus following assisted reproduction technology treatment. Hum Reprod. 2013;28(9):2554–61.CrossRef
6.
go back to reference Saisho Y, Miyakoshi K, Tanaka M, Shimada A, Ikenoue S, Kadohira I, et al. Beta cell dysfunction and its clinical significance in gestational diabetes. Endocr J. 2010;57(11):973–80.CrossRef Saisho Y, Miyakoshi K, Tanaka M, Shimada A, Ikenoue S, Kadohira I, et al. Beta cell dysfunction and its clinical significance in gestational diabetes. Endocr J. 2010;57(11):973–80.CrossRef
7.
go back to reference Abell SK, De Courten B, Boyle JA, Teede HJ. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci. 2015;16(6):13442–73.CrossRef Abell SK, De Courten B, Boyle JA, Teede HJ. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci. 2015;16(6):13442–73.CrossRef
8.
go back to reference Association AD. 13. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S137–S43.CrossRef Association AD. 13. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes—2018. Diabetes Care. 2018;41(Supplement 1):S137–S43.CrossRef
9.
go back to reference Simeonova-Krstevska S, Bogoev M, Bogoeva K, Zisovska E, Samardziski I, Velkoska-Nakova V, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Macedonian J Med Sci. 2018;6(5):803.CrossRef Simeonova-Krstevska S, Bogoev M, Bogoeva K, Zisovska E, Samardziski I, Velkoska-Nakova V, et al. Maternal and neonatal outcomes in pregnant women with gestational diabetes mellitus treated with diet, metformin or insulin. Open Access Macedonian J Med Sci. 2018;6(5):803.CrossRef
10.
go back to reference Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017;7(6):2016–015557.CrossRef Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, et al. Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. 2017;7(6):2016–015557.CrossRef
11.
go back to reference Barnes RA, Wong T, Ross GP, Jalaludin BB, Wong VW, Smart CE, et al. A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus. Diabetologia. 2016;59(11):2331–8.CrossRef Barnes RA, Wong T, Ross GP, Jalaludin BB, Wong VW, Smart CE, et al. A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus. Diabetologia. 2016;59(11):2331–8.CrossRef
12.
go back to reference Sapienza AD, Francisco RPV, Trindade TC, Zugaib M. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract. 2010;88(1):81–6.CrossRef Sapienza AD, Francisco RPV, Trindade TC, Zugaib M. Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Res Clin Pract. 2010;88(1):81–6.CrossRef
13.
go back to reference Kouhkan A, Khamseh ME, Moini A, Pirjani R, Valojerdi AE, Arabipoor A, et al. Predictive factors of gestational diabetes in pregnancies following assisted reproductive technology: a nested case–control study. Arch Gynecol Obstet. 2018;298(1):199-06.CrossRef Kouhkan A, Khamseh ME, Moini A, Pirjani R, Valojerdi AE, Arabipoor A, et al. Predictive factors of gestational diabetes in pregnancies following assisted reproductive technology: a nested case–control study. Arch Gynecol Obstet. 2018;298(1):199-06.CrossRef
14.
go back to reference Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy? Aust N Z J Obstet Gynaecol. 2011;51(5):432–6.CrossRef Jalaludin B. Gestational diabetes mellitus: who requires insulin therapy? Aust N Z J Obstet Gynaecol. 2011;51(5):432–6.CrossRef
15.
go back to reference Mitra S, Nayak PK, Sahoo J, Mathew A, Padma A, Kamalanathan S, et al. Predictors for antenatal insulin requirement in gestational diabetes. Gynecol Endocrinol. 2014;30(8):565–8.CrossRef Mitra S, Nayak PK, Sahoo J, Mathew A, Padma A, Kamalanathan S, et al. Predictors for antenatal insulin requirement in gestational diabetes. Gynecol Endocrinol. 2014;30(8):565–8.CrossRef
16.
go back to reference Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and risk factors of gestational diabetes in Iran: a systematic review and meta-analysis. Iran J Public Health. 2015;44(8):1036.PubMedPubMedCentral Jafari-Shobeiri M, Ghojazadeh M, Azami-Aghdash S, Naghavi-Behzad M, Piri R, Pourali-Akbar Y, et al. Prevalence and risk factors of gestational diabetes in Iran: a systematic review and meta-analysis. Iran J Public Health. 2015;44(8):1036.PubMedPubMedCentral
17.
go back to reference Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2014;9(3):e92485.CrossRef Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2014;9(3):e92485.CrossRef
18.
go back to reference Chen M, Wu L, Zhao J, Wu F, Davies MJ, Wittert GA, et al. Altered glucose metabolism in mouse and humans conceived by in-vitro fertilization (IVF). Diabetes. 2014;63(10):3189-98.CrossRef Chen M, Wu L, Zhao J, Wu F, Davies MJ, Wittert GA, et al. Altered glucose metabolism in mouse and humans conceived by in-vitro fertilization (IVF). Diabetes. 2014;63(10):3189-98.CrossRef
19.
go back to reference Watanabe M, Katayama A, Kagawa H, Ogawa D, Wada J. Risk factors for the requirement of antenatal insulin treatment in gestational diabetes mellitus. J Diabetes Res. 2016;2016:9648798.CrossRef Watanabe M, Katayama A, Kagawa H, Ogawa D, Wada J. Risk factors for the requirement of antenatal insulin treatment in gestational diabetes mellitus. J Diabetes Res. 2016;2016:9648798.CrossRef
20.
go back to reference Pertot T, Molyneaux L, Tan K, Ross GP, Yue DK, Wong J. Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus? Diabetes Care. 2011;34(10):2214–6.CrossRef Pertot T, Molyneaux L, Tan K, Ross GP, Yue DK, Wong J. Can common clinical parameters be used to identify patients who will need insulin treatment in gestational diabetes mellitus? Diabetes Care. 2011;34(10):2214–6.CrossRef
21.
go back to reference Bakiner O, Bozkirli E, Ozsahin K, Sariturk C, Ertorer E. Risk factors that can predict antenatal insulin need in gestational diabetes. J Clin Med Res. 2013;5(5):381.PubMedPubMedCentral Bakiner O, Bozkirli E, Ozsahin K, Sariturk C, Ertorer E. Risk factors that can predict antenatal insulin need in gestational diabetes. J Clin Med Res. 2013;5(5):381.PubMedPubMedCentral
22.
go back to reference Meshel S, Schejter E, Harel T, Maslovitz S, Germez N, Elimelech B, et al. Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes? J Matern Fetal Neonatal Med. 2016;29(13):2062–6.CrossRef Meshel S, Schejter E, Harel T, Maslovitz S, Germez N, Elimelech B, et al. Can we predict the need for pharmacological treatment according to demographic and clinical characteristics in gestational diabetes? J Matern Fetal Neonatal Med. 2016;29(13):2062–6.CrossRef
23.
go back to reference González-Quintero VH, Istwan NB, Rhea DJ, Tudela CM, Flick AA, De la Torre L, et al. Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes. J Women's Health. 2008;17(7):1183–7.CrossRef González-Quintero VH, Istwan NB, Rhea DJ, Tudela CM, Flick AA, De la Torre L, et al. Antenatal factors predicting subsequent need for insulin treatment in women with gestational diabetes. J Women's Health. 2008;17(7):1183–7.CrossRef
24.
go back to reference Cerny D, Sartori C, Rimoldi SF, Meister T, Soria R, Bouillet E, et al. Assisted reproductive technologies predispose to insulin resistance and obesity in male mice challenged with a high-fat diet. Endocrinology. 2017;158(5):1152–9.CrossRef Cerny D, Sartori C, Rimoldi SF, Meister T, Soria R, Bouillet E, et al. Assisted reproductive technologies predispose to insulin resistance and obesity in male mice challenged with a high-fat diet. Endocrinology. 2017;158(5):1152–9.CrossRef
25.
go back to reference Szymanska M, Horosz E, Szymusik I, Bomba-Opon D, Wielgos M. Gestational diabetes in IVF and spontaneous pregnancies. Neuro Endocrinol Lett. 2011;32(6):885–8.PubMed Szymanska M, Horosz E, Szymusik I, Bomba-Opon D, Wielgos M. Gestational diabetes in IVF and spontaneous pregnancies. Neuro Endocrinol Lett. 2011;32(6):885–8.PubMed
26.
go back to reference Nunes VA, Portioli-Sanches EP, Rosin MP, da Silva Araújo M, Praxedes-Garcia P, Valle MM, et al. Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism. Journal of Endocrinology. 2014;221(2):273–84.CrossRef Nunes VA, Portioli-Sanches EP, Rosin MP, da Silva Araújo M, Praxedes-Garcia P, Valle MM, et al. Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism. Journal of Endocrinology. 2014;221(2):273–84.CrossRef
27.
go back to reference Wada T, Hori S, Sugiyama M, Fujisawa E, Nakano T, Tsuneki H, et al. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am J Physiol-Endocrinol Metab. 2010;298(4):E881–E8.CrossRef Wada T, Hori S, Sugiyama M, Fujisawa E, Nakano T, Tsuneki H, et al. Progesterone inhibits glucose uptake by affecting diverse steps of insulin signaling in 3T3-L1 adipocytes. Am J Physiol-Endocrinol Metab. 2010;298(4):E881–E8.CrossRef
28.
go back to reference Yildizfer F, Donma O, Yen M, Ekmekci O, Kul ZAK, Keser Z, et al. In vitro fertilization, levels of pro-inflammatory factors and lipid peroxidation. Int J Fertility Sterility. 2015;9(3):277. Yildizfer F, Donma O, Yen M, Ekmekci O, Kul ZAK, Keser Z, et al. In vitro fertilization, levels of pro-inflammatory factors and lipid peroxidation. Int J Fertility Sterility. 2015;9(3):277.
29.
go back to reference Kumari R, Singh H. The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus. J Fam Med Primary Care. 2017;6(2):259.CrossRef Kumari R, Singh H. The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus. J Fam Med Primary Care. 2017;6(2):259.CrossRef
30.
go back to reference Brahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam study. Eur J Epidemiol. 2017;32(3):217–26.CrossRef Brahimaj A, Ligthart S, Ghanbari M, Ikram MA, Hofman A, Franco OH, et al. Novel inflammatory markers for incident pre-diabetes and type 2 diabetes: the Rotterdam study. Eur J Epidemiol. 2017;32(3):217–26.CrossRef
Metadata
Title
Assisted conception as a potential prognostic factor predicting insulin therapy in pregnancies complicated by gestational diabetes mellitus
Authors
Azam Kouhkan
Hamid Reza Baradaran
Roya Hosseini
Arezoo Arabipoor
Ashraf Moini
Reihaneh Pirjani
Alireza Khajavi
Mohammad E. Khamseh
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2019
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-019-0525-4

Other articles of this Issue 1/2019

Reproductive Biology and Endocrinology 1/2019 Go to the issue